@currentmedscience.bsky.socialWhy is #CD44v6 exciting in AML?
#Decitabine treatment increases CD44v6 expression on DNMT3A-mutant AML cells, improving recognition & targeting by #CARTcells. A promising step toward precision #Immunotherapy. #medsky
Read: doi.org/10.1007/s115...
#currentmedicalscience #Oncology
@carlus-2024.bsky.socialSeptember 10, 2026
👉 What if the next “checkpoint” in immunotherapy were found… in the lymph nodes?
🙂 Another encouraging news from Groupe UIG.
Read: www.nature.com/articles/s41...
#CancerResearch #Immunotherapy #SpatialBiology #SingleCell #Oncology #LifeSciences
@carlus-2024.bsky.social10 septembre 2026
👉 Et si le prochain « checkpoint » de l’immunothérapie se trouvait… dans les ganglions lymphatiques?
🙂 Une autre nouvelle encourageante du Groupe UIG.
Lire: www.nature.com/articles/s41...
#CancerResearch #Immunotherapy #SpatialBiology #SingleCell
@dctomaz.bsky.social🧬 Antibodies don't just block. They can switch things on — and that agonistic potential is where the next wave of patient benefit can possibly be.
Cragg, Yu, Paluch & Simon Davis on how to get there.
doi.org/10.1038/s41573-026-01442-2
@thecancersurvivorsclub.comPromising cancer research: scientists have engineered ready-to-use T cells that attacked solid tumours in laboratory and mouse studies, potentially opening the door to more accessible cell therapies.
@melanomafocus.bsky.socialWe’re excited to have Professor Ricky on board and look forward to the knowledge and patient-centered perspective he’ll bring to Melanoma Focus.
Welcome, Ricky! 💙
@agentictribune.bsky.socialDurvalumab Plus FLOT Boosts Survival in Resectable Gastric and GEJ Cancer, MATTERHORN Shows
#oncology #immunotherapy #durvalumab #gastric-cancer #astrazeneca
@pharmaphorum.bsky.social#Amgen's fast-growing cancer #immunotherapy #Imdelltra could move into the first-line setting in #smallcelllungcancer (SCLC), after delivering as a #dualregimen with AstraZeneca's Imfinzi in the DeLLphi-305 study.
@genesndiseases.bsky.socialPrecision medicine is transforming #cholangiocarcinoma care.
This review highlights advances in targeted therapies and #immunotherapy while addressing challenges such as drug resistance and biomarker discovery. #TumorMicroenvironment
#GenesAndDiseases: doi.org/10.1016/j.ge...
@transpread.bsky.socialA research team has published a comprehensive review in Cancer Biology & Medicine that systematically evaluates the microbiome’s role in lung cancer immunotherapy.
#Lung cancer #Immunotherapy
Details: doi.org/10.20892/j.i...
@carlus-2024.bsky.socialSeptember 9, 2026
👉 What if fewer CAR-T cells could sometimes deliver… greater efficacy?
🙂 Another encouraging news from Groupe UIG.
Read: medicalxpress.com/news/2026-09...
#CAR_T #CARtherapy #CancerResearch #Immunotherapy #ImmunoOncology
@newsen.bsky.socialHanchorBio Achieves FDA Milestone for HCB101 in Patient Treatment Continuation #Taipei #USA #Immunotherapy #HanchorBio #HCB101
@sigtrans-sttt.bsky.socialWhat shapes #Immunotherapy response in #ESCC?
A single-cell immune atlas reveals central memory T-cell depletion in tumours and identifies PD-L1⁺ #macrophages and CD39⁺ tumour-infiltrating T cells as clinically relevant immune features.
@thecancersurvivorsclub.comEncouraging progress in lymphoma treatment. CAR T-cell therapy, bispecific antibodies and targeted treatments are giving patients more options, including potentially curative treatments.
@sigtrans-sttt.bsky.socialT cell exhaustion and #Senescence impose distinct barriers to #Cancer #Immunotherapy.
This review explores their molecular hallmarks and emerging immune-rejuvenation strategies for checkpoint blockade and adoptive cell therapies.
@sigtrans-sttt.bsky.socialCan immune checkpoint therapies developed for #Cancer #Immunotherapy restore metabolic balance?
This review explores PD-1/PD-L1-mediated immunometabolic regulation in #Obesity,
#Diabetes, and thyroid disease and its therapeutic potential.
@epigenometech.bsky.socialEpigenetics Update - Cyclin E-CDK2 regulates cancer cell transcriptional program and response to immunotherapy through BRD4 u.epigenome.us/6Xjrfeuf
Kai W. Wucherpfennig & Piotr Sicinski in Mol Cell
#Epigenetics #Cancer #Immunotherapy #BRD4
---
Cancer, immunology, and aging; epigenometech.com
@estroradiotherapy.bsky.social#Radiotherapy isn't just local—it can trigger an immune response to fight cancer beyond the treated area (the abscopal effect).
Prof Anna Dubrovska on combining radiotherapy + #immunotherapy 🧬
🎥 https://bit.ly/4qWxRuM
#WRAD #Radonc @WorldRTDay #WorldRadiotherapyAwarenessDay
@thebabaklab.bsky.socialMerck and Moderna have announced positive top-line results from the Phase 3 INTerpath-001 trial of intismeran autogene (V940) + pembrolizumab in patients with resected high-risk melanoma.
Link in the comments 👇
#ClinicalMondays #Melanoma #CancerVaccine #mRNA #Immunotherapy
@gmj-georgia.bsky.social🧠 Early clinical trial data show high-dose vitamin B3 (niacin) may restore immune function against glioblastoma—one of the brain's deadliest cancers. By re… #Braincancer #Clinicaltrial #Glioblastoma #Immuneexhaustion #Immunotherapy #Braincancer #Clinicaltrial #Glioblastoma #Immuneexhaustion #Im…